Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 99


Change is in the air: the hypoxic induction of phenotype switching in melanoma.

O'Connell MP, Weeraratna AT.

J Invest Dermatol. 2013 Oct;133(10):2316-2317. doi: 10.1038/jid.2013.208.


Hypoxia contributes to melanoma heterogeneity by triggering HIF1α-dependent phenotype switching.

Widmer DS, Hoek KS, Cheng PF, Eichhoff OM, Biedermann T, Raaijmakers MIG, Hemmi S, Dummer R, Levesque MP.

J Invest Dermatol. 2013 Oct;133(10):2436-2443. doi: 10.1038/jid.2013.115. Epub 2013 Mar 8.


Endothelin-1 and endothelin-3 promote invasive behavior via hypoxia-inducible factor-1alpha in human melanoma cells.

Spinella F, Rosanò L, Di Castro V, Decandia S, Nicotra MR, Natali PG, Bagnato A.

Cancer Res. 2007 Feb 15;67(4):1725-34.


Hypoxia-Inducible Factor-1α and CD271 inversely correlate with melanoma invasiveness.

Marconi A, Borroni RG, Truzzi F, Longo C, Pistoni F, Pellacani G, Pincelli C.

Exp Dermatol. 2015 May;24(5):396-8. doi: 10.1111/exd.12679.


Hypoxia and MITF control metastatic behaviour in mouse and human melanoma cells.

Cheli Y, Giuliano S, Fenouille N, Allegra M, Hofman V, Hofman P, Bahadoran P, Lacour JP, Tartare-Deckert S, Bertolotto C, Ballotti R.

Oncogene. 2012 May 10;31(19):2461-70. doi: 10.1038/onc.2011.425. Epub 2011 Sep 26.


Hypoxia promotes uveal melanoma invasion through enhanced Notch and MAPK activation.

Asnaghi L, Lin MH, Lim KS, Lim KJ, Tripathy A, Wendeborn M, Merbs SL, Handa JT, Sodhi A, Bar EE, Eberhart CG.

PLoS One. 2014 Aug 28;9(8):e105372. doi: 10.1371/journal.pone.0105372. eCollection 2014.


Inhibition of autophagy with chloroquine is effective in melanoma.

Egger ME, Huang JS, Yin W, McMasters KM, McNally LR.

J Surg Res. 2013 Sep;184(1):274-81. doi: 10.1016/j.jss.2013.04.055. Epub 2013 May 17.


Engineering melanoma progression in a humanized environment in vivo.

Kiowski G, Biedermann T, Widmer DS, Civenni G, Burger C, Dummer R, Sommer L, Reichmann E.

J Invest Dermatol. 2012 Jan;132(1):144-53. doi: 10.1038/jid.2011.275. Epub 2011 Sep 1.


[Expression of hypoxia-inducible factor-1 alpha and vascular endothelial growth factor in malignant melanoma].

Cheng Y, Luo Y, Zhou YS, Wu HY, Xie ZB.

Zhonghua Zheng Xing Wai Ke Za Zhi. 2009 Mar;25(2):134-6. Chinese.


The Wnts of change: How Wnts regulate phenotype switching in melanoma.

Webster MR, Kugel CH 3rd, Weeraratna AT.

Biochim Biophys Acta. 2015 Dec;1856(2):244-51. doi: 10.1016/j.bbcan.2015.10.002. Epub 2015 Nov 4. Review.


Prognostic relevance of hypoxia inducible factor-1alpha expression in patients with melanoma.

Valencak J, Kittler H, Schmid K, Schreiber M, Raderer M, Gonzalez-Inchaurraga M, Birner P, Pehamberger H.

Clin Exp Dermatol. 2009 Dec;34(8):e962-4. doi: 10.1111/j.1365-2230.2009.03706.x.


The immunohistochemistry of invasive and proliferative phenotype switching in melanoma: a case report.

Eichhoff OM, Zipser MC, Xu M, Weeraratna AT, Mihic D, Dummer R, Hoek KS.

Melanoma Res. 2010 Aug;20(4):349-55. doi: 10.1097/CMR.0b013e32833bd89e.


The critical role of mast cell-derived hypoxia-inducible factor-1α in human and mice melanoma growth.

Jeong HJ, Oh HA, Nam SY, Han NR, Kim YS, Kim JH, Lee SJ, Kim MH, Moon PD, Kim HM, Oh HA.

Int J Cancer. 2013 Jun 1;132(11):2492-501. doi: 10.1002/ijc.27937. Epub 2012 Dec 3.


HIF-1α stabilization by mitochondrial ROS promotes Met-dependent invasive growth and vasculogenic mimicry in melanoma cells.

Comito G, Calvani M, Giannoni E, Bianchini F, Calorini L, Torre E, Migliore C, Giordano S, Chiarugi P.

Free Radic Biol Med. 2011 Aug 15;51(4):893-904. doi: 10.1016/j.freeradbiomed.2011.05.042. Epub 2011 Jun 12.


Hypoxia-inducible factor 1 upregulation of both VEGF and ANGPTL4 is required to promote the angiogenic phenotype in uveal melanoma.

Hu K, Babapoor-Farrokhran S, Rodrigues M, Deshpande M, Puchner B, Kashiwabuchi F, Hassan SJ, Asnaghi L, Handa JT, Merbs S, Eberhart CG, Semenza GL, Montaner S, Sodhi A.

Oncotarget. 2016 Feb 16;7(7):7816-28. doi: 10.18632/oncotarget.6868.


Sporadic cutaneous angiosarcomas generally lack hypoxia-inducible factor 1alpha: a histologic and immunohistochemical study of 45 cases.

Abedalthagafi M, Rushing EJ, Auerbach A, Desouki MM, Marwaha J, Wang Z, Fanburg-Smith JC.

Ann Diagn Pathol. 2010 Feb;14(1):15-22. doi: 10.1016/j.anndiagpath.2009.09.005. Epub 2009 Dec 11.


HIF1α and HIF2α independently activate SRC to promote melanoma metastases.

Hanna SC, Krishnan B, Bailey ST, Moschos SJ, Kuan PF, Shimamura T, Osborne LD, Siegel MB, Duncan LM, O'Brien ET 3rd, Superfine R, Miller CR, Simon MC, Wong KK, Kim WY.

J Clin Invest. 2013 May;123(5):2078-93. doi: 10.1172/JCI66715. Epub 2013 Apr 8.


Therapeutic improvement of a stroma-targeted CRAd by incorporating motives responsive to the melanoma microenvironment.

Viale DL, Cafferata EG, Gould D, Rotondaro C, Chernajovsky Y, Curiel DT, Podhajcer OL, Veronica Lopez M.

J Invest Dermatol. 2013 Nov;133(11):2576-2584. doi: 10.1038/jid.2013.191. Epub 2013 Apr 19.


Involvement of the mRNA binding protein CRD-BP in the regulation of metastatic melanoma cell proliferation and invasion by hypoxia.

Craig EA, Weber JD, Spiegelman VS.

J Cell Sci. 2012 Dec 15;125(Pt 24):5950-4. doi: 10.1242/jcs.115204. Epub 2012 Oct 4.


Hypoxia: dual effect on the expression of transferrin receptor in human melanoma A375 cell line.

Tao J, Liu YQ, Li Y, Peng JL, Li L, Liu J, Shen X, Shen GX, Tu YT.

Exp Dermatol. 2007 Nov;16(11):899-904.


Supplemental Content

Support Center